Загрузка...

Alembic Pharma Bets Big On US Branded Drugs With New Launch | Next Big Growth Engine | ET Now

Alembic Pharma MD Pranav Amin breaks down the company’s Q4 performance, rising R&D investments, and ambitious expansion plans in the US branded pharmaceuticals market. Despite higher one-time expenses, the company reported strong profit growth and expects double-digit revenue growth going ahead.

From peptide development and branded drug launches like Pivya to US growth, injectables, APIs, and new manufacturing facilities. Here’s a complete look at Alembic Pharma’s long-term growth strategy and FY27 outlook.

control your money with economic times now.

#etnow #businessnews #alembicpharma #pharma #healthcarestocks #stockmarket #uspharma #pharmaceuticals #earnings

YouTube Channel - https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC

Website - https://www.etnownews.com
Download our App for Breaking News: https://tinyurl.com/4y6e3u2e
Follow us on Google News for latest updates
ET Now: https://news.google.com/publications/CAAqBwgKMK3HxQsw0OLcAw?hl=en-IN&gl=IN&ceid=IN%3Aen
Times Now Navbharat: https://bit.ly/3zDaKJo
Times Now : https://bit.ly/3CyrrYg
Zoom: https://bit.ly/3CEK0dv

Видео Alembic Pharma Bets Big On US Branded Drugs With New Launch | Next Big Growth Engine | ET Now канала ET Now
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять